Stay updated on Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s footer revision identifier was updated from **v3.5.2** to **v3.5.3**, indicating a minor site/version release without changing the study content.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check63 days agoChange DetectedSite platform updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision banner updated to v3.4.2; the previous notices about funding lapses and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check99 days agoChange DetectedA site-wide notice about government funding delays and current operating status is added, and the page shows a revision update to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

Stay in the know with updates to Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.